X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-04-11 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $14.49 | -485,000 | 3,518,967 | -12% | -$7,026,033 | |||||
| M | 2024-02-02 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $15.09 | -17,589 | 77,762 | -18% | -$265,401 | |||||
| M | 2024-01-30 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $15.09 | -13,848 | 95,351 | -13% | -$208,965 | |||||
| M | 2024-01-24 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $15.03 | -828 | 109,199 | -1% | -$12,441 | |||||
| M | 2023-12-26 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $10.12 | -13,402 | 110,027 | -11% | -$135,668 | |||||
2023-12-20 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $10.14 | -2,730 | 123,429 | -2% | -$27,695 | ||||||
2023-12-06 | NPCE | Morrell Martha | Chief Medical officer | S - Sale | $8.16 | -11,005 | 126,159 | -8% | -$89,773 | ||||||
| M | 2023-11-29 | NPCE | Kck Ltd. | 10% | S - Sale | $8.78 | -16,167 | 5,593,773 | 0% | -$141,882 | |||||
| M | 2023-11-27 | NPCE | Kck Ltd. | 10% | S - Sale | $8.87 | -11,171 | 5,609,940 | 0% | -$99,109 | |||||
| M | 2023-10-02 | NPCE | Orbimed Advisors LLC | 10% | S - Sale | $9.07 | -8,314 | 4,003,967 | 0% | -$75,449 | |||||
| M | 2022-11-21 | NPCE | Accelmed Partners II L.P. | 10% | P - Purchase | $1.50 | +390,291 | 4,432,948 | +10% | +$585,046 | |||||
2022-06-08 | NPCE | Ridley Irina | GC, Secretary | S - Sale | $5.78 | -2,500 | 61,139 | -4% | -$14,445 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |